explore -WSS

explore

author：leisure time 2025-10-02 23:47:23 - browse：83565

Babies born by in vitro fertilization — when a woman’s egg is fertilized outside of her body and then implanted back into her uterus — skew more heavily male than babies conceived naturally. A study published Monday in the Proceedings of the National Academy of Sciences sheds light on why that happens.

You’ll want to know:

During normal development, female embryos usually shut down the activity of one of their two X chromosomes to keep gene expression levels the same as in male embryos. But researchers at the China Agricultural University saw that this process often went awry in mouse embryos created by IVF. Those female embryos were defective and didn’t develop properly. Researchers said it might be possible to fix the problem by adding a particular chemical (a derivative of vitamin A) to embryos in the lab dish before they’re implanted.

The background:

More than 5 million people have been born using IVF since it was pioneered in 1978. Skewed sex ratio has been debated for decades; one 2010 study found IVF produced as many as 128 boys born for every 100 girls.

Keep in mind:

The study was carried out on IVF embryos in mice, with naturally conceived mouse embryos as the control group. While mice are a commonly used research subject, findings in rodents don’t always translate directly to the biology of humans.

Also note that IVF births account for just 1 to 2 percent of total births in the United States, so having more males born via fertility treatments is unlikely to affect the gender ratio of babies nationwide. “I don’t think anyone should be worried even if there’s a slight increase in male births in patients undergoing fertility care,” said Dr. Mark Sauer, an obstetrician and gynecologist at Columbia University Medical Center, who was not involved in the study.

The bottom line:

Scientists might have figured out the cause for the skewed sex ratio that shows up in IVF births, but it’s not clear yet whether the strategies they propose to fix the issue will work in practice.

Previous article： Drug repurposing or repositioning? The language matters
Next article： Timeline: How the deadly wildfires took over Maui day by day

WSS

Treatments for cramps don't cut it. Why aren't there better options?

Novo Nordisk touts Wegovy study, but still struggling with supply

Woman returns to dialysis after doctors remove transplanted pig kidney

Senators push IRS to launch nonprofit hospital probe

ASCO: AstraZeneca says CAR

Readout LOUD podcast: ASCO preview, a Duchenne trial failure

focus

explore

You’ll want to know:

The background:

Keep in mind:

The bottom line:

explore

In age of alternative facts, a scholarly course on calling out crap

Change Healthcare can notify patients about the breach, HHS says

Sports medicine is finally prioritizing gender equality

Kaiser's Risant Health gobbled up Geisinger. Who is next?

Dobbs anniversary: the lost opportunity of abortion as health care

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

In Memoriam: Notable people who died in 2023

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

Psychedelics group wrestles with new pharma identity

Novo Nordisk touts Wegovy study, but still struggling with supply

explore

Surge in Apellis stock fueled by confidence in safety of its eye drug

Illinois Supreme Court finds assault weapons ban constitutional

Letters to First Opinion on caregivers, digital health, and more

Let's speed up science by embracing open access publishing

Change Healthcare can notify patients about the breach, HHS says

FDA's Pazdur wants cancer trials to range beyond China alone

hotspot

focus

Wikipedia

focus